Virginia Retirement Systems Et Al Arcellx, Inc. Transaction History
Virginia Retirement Systems Et Al
- $15 Billion
- Q3 2025
A detailed history of Virginia Retirement Systems Et Al transactions in Arcellx, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 3,100 shares of ACLX stock, worth $265,422. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,100Holding current value
$265,422% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACLX
# of Institutions
223Shares Held
49.1MCall Options Held
245KPut Options Held
885K-
Paradigm Biocapital Advisors LP New York, NY4.65MShares$398 Million14.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.94MShares$338 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$321 Million20.45% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$301 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.04MShares$260 Million4.37% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.75B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...